Medscheme's Medicine Price List (MPL) is a reference pricing system developed by our Medical and Health Services Managers that uses a benchmark price for generically similar products.
The fundamental principle of any reference pricing system is that it does not restrict your choice of medicines, but instead limits the amount that will be paid.
MPL reference prices are set in such a way as to ensure availability of medicines without co-payments. In other words, you will be able to afford the medicine you need without paying from your own pocket, but you will have to select the most cost-effective product.
MPL Groupings are Established for:
- Products registered on the basis of generic equivalence – same ingredient(s), same strength, same formulation.
- Products that are generically similar. Medscheme's definition for generic similarity refers to products that contain the same active ingredients, at the same effective strength, but:
- The formulation may differ (tablets vs. capsules; slow-release vs. immediate release)
- The salt/ester of the preparations may differ – calcium and erythromycin compounds – no convincing clinical superiority has been demonstrated for any of these differences
Download and view MPL Oncology List
Download and view MPL Complete List
Download and view MPL Changes
